NanoEntek, Inc.

Research NanoEntek, Inc. (039860.KQ) on Bullrun: market cap KRW 162.73B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is KRW 162.73B.

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18KRW 162.73Bn/an/an/a

Dividend history

About NanoEntek, Inc.

NanoEntek, Inc. engages in the research and development, production, and sale of life-science lab equipment, in vitro diagnostic medical devices, point of care diagnostic devices, and related consumables and solutions in Korea and internationally. It provides FREND system, a fluorescence immunoassay analyzer; BUDDI, a rapid diagnostic test analyzer; rapid diagnostic test items; ADAM-rWBC, a residual white blood cell counters; ADAMII/fluorescence stem cell counter; fluorescence cell counters and cell analyzers;

Related stock research

South Korea stocks South Korea Technology stocks A-Z stock index

Other Technology stocks

ELP Corporation (063760.KQ) Kweather Co., Ltd (068100.KQ) THINKWARE Corporation (084730.KQ) Suprema HQ Inc. (094840.KQ) Woojin Inc. (105840.KS) HyVision System. Inc (126700.KQ) DAIHAN Scientific Co., Ltd. (131220.KQ) Park Systems Corp. (140860.KQ) SolDefense Co., Ltd. (215090.KQ) V-One Tech Co., Ltd. (251630.KQ) HB SOLUTION Co., Ltd. (297890.KQ) HanWool Semiconductor, Inc. (320000.KQ)

Frequently asked questions

What is NanoEntek, Inc.'s market cap?

NanoEntek, Inc.'s market capitalization is KRW 162.73B.

What does NanoEntek, Inc. do?

NanoEntek, Inc. engages in the research and development, production, and sale of life-science lab equipment, in vitro diagnostic medical devices, point of care diagnostic devices, and related consumables and solutions in Korea and internationally.